---
title: "Betamethasone - Crohn's disease"
sidebar: mydoc_sidebar
permalink: db00443-mesh-d003424-1.html
toc: false 
---


Path ID: `DB00443_MESH_D003424_1`
{% include image.html url="images/db00443-mesh-d003424-1.png" file="db00443-mesh-d003424-1.png" alt="db00443-mesh-d003424-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D001623 | betamethasone | Drug |
| UniProt:P04150 | Glucocorticoid receptor | Protein |
| UniProt:P47712 | Phospholipase A2 | Protein |
| GO:0006954 | Inflammation | BiologicalProcess |
| MESH:D003424 | Crohn's disease | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Betamethasone | INCREASES ACTIVITY OF | Glucocorticoid Receptor |
| Glucocorticoid Receptor | DECREASES ABUNDANCE OF | Phospholipase A2 |
| Phospholipase A2 | POSITIVELY REGULATES | Inflammation |
| Inflammation | POSITIVELY CORRELATED WITH | Crohn'S Disease |
|---------|-----------|---------|

Reference:
  - [https://go.drugbank.com/drugs/DB00443#mechanism-of-action](https://go.drugbank.com/drugs/DB00443#mechanism-of-action){:target="_blank"}